Earnings

Burn-in testing stresses chips with heat and voltage to expose early failures before they reach customers, which matters for expensive AI processors. Aehr said a lead AI processor customer placed a USD 22 million follow-on order in August 2026, and that a major AI …

No company announcement dated November 2 to November 4, 2026 was identified, and the company has not yet published third quarter results. It has said it will give a fuller update on its November 2026 earnings call, so the move looks like positioning ahead …

Lattice designs low-power programmable chips, known as field programmable gate arrays, that customers configure after manufacture to handle tasks such as communications, computing and industrial control. Revenue growth accelerated, since the second quarter had risen 62% according to published coverage of that report. Fourth-quarter …

IDEXX raised its 2026 outlook for revenue to USD 4.741 billion to USD 4.767 billion, organic growth to 9.3% to 10.0% and earnings to USD 14.96 to USD 15.16. The operating margin range of 32.1% to 32.3% is lower than the 32.3% to 32.5% …

Tempus sells genomic tests to doctors and licenses de-identified clinical and molecular data to drug makers, which use it to design trials. The two lines feed each other: tests add data, and data licensing carries high margins. Published coverage cites a collaboration with a …

The shares fell despite the beat, and published coverage points to three concerns. Per-share growth leaned on buybacks, since the share count is down about 15% to roughly 64 million. NewBusinessfell about 4% in the technology sales group and about 3% in the business …

Dynatrace closed itsAcquisitionof Arize, an AI observability company, on October 1, 2026. Published coverage puts the price at about USD 915 million. Guidance now includes about 200 basis points of annual recurring revenue growth from Arize, so fiscal 2027 annual recurring revenue guidance rose …